Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Retained Earnings of $193.4 million for Q1 2026, up 78835.1% on a YoY basis from N/an in Q1 2025, and up 55793.35% sequentially from $346000.0 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Retained Earnings data on file, last reported at $193.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 78835.1% year-over-year to $193.4 million; the trailing twelve-month figure through Mar 2026 stood at $193.4 million (up 78835.1% YoY), and the FY2025 full-year result was $346000.0, down 84.39% from the prior year.
- Retained Earnings advanced to $193.4 million in Q1 2026, from $346000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $193.4 million in Q1 2026 to a low of -$432.1 million in Q1 2022.
- A 5-year average of -$42.7 million and a median of -$29000.0 in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 1700.0% in 2023 and jumped 110700.0% in 2024, its largest moves.
- Tracing HRMY's Retained Earnings over 5 years: stood at -$151000.0 in 2022, then soared by 101.32% to $2000.0 in 2023, then jumped by 110700.0% to $2.2 million in 2024, then sank by 84.39% to $346000.0 in 2025, then jumped by 55793.35% to $193.4 million in 2026.
- Business Quant data shows HRMY's Retained Earnings at $193.4 million in Q1 2026, $346000.0 in Q4 2025, and $357000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 193.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.39 Mn |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 245,000.00 |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 499,000.00 |
| Jun 30, 2024 | -234,000.00 |
| Mar 31, 2024 | -171,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | -169.88 Mn |
| Jun 30, 2023 | -522,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -320.64 Mn |
| Jun 30, 2022 | -29,000.00 |
| Mar 31, 2022 | -432.11 Mn |
| Dec 31, 2021 | -453.60 Mn |
| Sep 30, 2021 | -476.31 Mn |
| Jun 30, 2021 | -466.69 Mn |